Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Rabbit Anti-CHEK1 (Phospho-Ser345) Recombinant Antibody (CBWJC-2030) (CBMAB-C2646WJ)

Online Inquiry

Summary

Host Animal
Rabbit
Specificity
Human
Clone
CBWJC-2030
Antibody Isotype
IgG
Application
WB

Basic Information

Immunogen
A synthetic peptide corresponding to residues around (Ser345) of Human Phospho-Chk1.
Host Species
Rabbit
Specificity
Human
Antibody Isotype
IgG
Clonality
Monoclonal Antibody
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.
ApplicationNote
WB1:2,000-1:20,000

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
None
Concentration
Batch dependent
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Checkpoint Kinase 1
Introduction
The protein encoded by this gene belongs to the Ser/Thr protein kinase family. It is required for checkpoint mediated cell cycle arrest in response to DNA damage or the presence of unreplicated DNA. This protein acts to integrate signals from ATM and ATR, two cell cycle proteins involved in DNA damage responses, that also associate with chromatin in meiotic prophase I. Phosphorylation of CDC25A protein phosphatase by this protein is required for cells to delay cell cycle progression in response to double-strand DNA breaks. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Oct 2011]
Entrez Gene ID
UniProt ID
Alternative Names
Checkpoint Kinase 1; Cell Cycle Checkpoint Kinase; CHK1 Checkpoint Homolog; EC 2.7.11.1; CHK1; Serine/Threonine-Protein Kinase Chk1; Checkpoint, S. Pombe, Homolog Of, 1;
Function
Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA (PubMed:11535615, PubMed:12446774, PubMed:12399544, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15665856, PubMed:15650047).
May also negatively regulate cell cycle progression during unperturbed cell cycles (PubMed:11535615, PubMed:12446774, PubMed:12399544, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15665856, PubMed:15650047).
This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome (PubMed:11535615, PubMed:12446774, PubMed:12399544, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15665856, PubMed:15650047).
Recognizes the substrate consensus sequence [R-X-X-S/T] (PubMed:11535615, PubMed:12446774, PubMed:12399544, PubMed:14559997, PubMed:14988723, PubMed:15311285, PubMed:15665856, PubMed:15650047).
Binds to and phosphorylates CDC25A, CDC25B and CDC25C (PubMed:9278511, PubMed:12676583, PubMed:14681206, PubMed:12676925, PubMed:12759351, PubMed:19734889, PubMed:14559997).
Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C (PubMed:9278511).
Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A (PubMed:9278511, PubMed:12676583, PubMed:14681206, PubMed:12676925, PubMed:12759351, PubMed:19734889).
Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A (PubMed:9278511, PubMed:19734889, PubMed:20090422).
Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression (PubMed:9278511).
Also phosphorylates NEK6 (PubMed:18728393).
Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination (PubMed:15665856).
Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation (PubMed:10673501, PubMed:15659650, PubMed:16511572).
Also promotes repair of DNA cross-links through phosphorylation of FANCE (PubMed:17296736).
Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A (PubMed:12660173, PubMed:12955071).
This may enhance chromatin assembly both in the presence or absence of DNA damage (PubMed:12660173, PubMed:12955071).
May also play a role in replication fork maintenance through regulation of PCNA (PubMed:18451105).
May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones (By similarity).
Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes (By similarity).
May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest (PubMed:17380128).
Phosphorylates SPRTN, promoting SPRTN recruitment to chromatin (PubMed:31316063).
Reduces replication stress and activates the G2/M checkpoint, by phosphorylating and inactivating PABIR1/FAM122A and promoting the serine/threonine-protein phosphatase 2A-mediated dephosphorylation and stabilization of WEE1 levels and activity (PubMed:33108758).
Isoform 2: Endogenous repressor of isoform 1, interacts with, and antagonizes CHK1 to promote the S to G2/M phase transition.
Biological Process
Apoptotic process Source: UniProtKB
Cellular response to DNA damage stimulus Source: UniProtKB
Cellular response to mechanical stimulus Source: UniProtKB
Chromatin-mediated maintenance of transcription Source: UniProtKB
DNA damage checkpoint Source: UniProtKB
DNA damage induced protein phosphorylation Source: UniProtKB
DNA repair Source: UniProtKB
DNA replication Source: Reactome
Intracellular signal transduction Source: GO_Central
Mitotic G2/M transition checkpoint Source: UniProtKB
Negative regulation of G0 to G1 transition Source: Reactome
Negative regulation of mitotic nuclear division Source: UniProtKB
Peptidyl-threonine phosphorylation Source: UniProtKB
Positive regulation of cell cycle Source: CAFA
Protein phosphorylation Source: UniProtKB
Regulation of double-strand break repair via homologous recombination Source: UniProtKB
Regulation of histone H3-K9 acetylation Source: UniProtKB
Regulation of mitotic centrosome separation Source: UniProtKB
Regulation of signal transduction by p53 class mediator Source: Reactome
Regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage Source: UniProtKB
Replicative senescence Source: BHF-UCL
Signal transduction involved in G2 DNA damage checkpoint Source: UniProtKB
Cellular Location
Centrosome; Nucleus; Cytoplasm; Chromosome. Nuclear export is mediated at least in part by XPO1/CRM1 (PubMed:12676962). Also localizes to the centrosome specifically during interphase, where it may protect centrosomal CDC2 kinase from inappropriate activation by cytoplasmic CDC25B (PubMed:15311285). Proteolytic cleavage at the C-terminus by SPRTN promotes removal from chromatin (PubMed:31316063).
PTM
Phosphorylated by ATR in a RAD17-dependent manner in response to ultraviolet irradiation and inhibition of DNA replication. Phosphorylated by ATM in response to ionizing irradiation. ATM and ATR can both phosphorylate Ser-317 and Ser-345 and this results in enhanced kinase activity. Phosphorylation at Ser-345 induces a change in the conformation of the protein, activates the kinase activity and is a prerequisite for interaction with FBXO6 and subsequent ubiquitination at Lys-436. Phosphorylation at Ser-345 also increases binding to 14-3-3 proteins and promotes nuclear retention. Conversely, dephosphorylation at Ser-345 by PPM1D may contribute to exit from checkpoint mediated cell cycle arrest. Phosphorylation at Ser-280 by AKT1/PKB, may promote mono and/or diubiquitination. Also phosphorylated at undefined residues during mitotic arrest, resulting in decreased activity.
Ubiquitinated. Mono or diubiquitination promotes nuclear exclusion (By similarity). The activated form (phosphorylated on Ser-345) is polyubiquitinated at Lys-436 by some SCF-type E3 ubiquitin ligase complex containing FBXO6 promoting its degradation. Ubiquitination and degradation are required to terminate the checkpoint and ensure that activated CHEK1 does not accumulate as cells progress through S phase, when replication forks encounter transient impediments during normal DNA replication.
Proteolytically cleaved at the C-terminus by SPRTN during normal DNA replication, thereby promoting CHEK1 removal from chromatin and activating the protein kinase activity.
More Infomation

Singh, R., Bhardwaj, V. K., Sharma, J., Das, P., & Purohit, R. (2021). Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants. Genomics, 113(1), 707-715.

Yan, Y., Zheng, L., Du, Q., Cui, X., Dong, K., Guo, Y., & Geller, D. A. (2021). Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells. British Journal of Cancer, 1-11.

Choi, C., Cho, W. K., Park, S., Shin, S. W., Park, W., Kim, H., & Choi, D. H. (2020). Checkpoint Kinase 1 (CHK1) inhibition enhances the sensitivity of triple-negative breast cancer cells to proton irradiation via Rad51 downregulation. International journal of molecular sciences, 21(8), 2691.

Mai, N. T., Lan, N. T., Vu, T. Y., Duong, P. T. M., Tung, N. T., & Phung, H. T. T. (2020). Estimation of the ligand-binding free energy of checkpoint kinase 1 via non-equilibrium MD simulations. Journal of Molecular Graphics and Modelling, 100, 107648.

Xie, L., Jia, L., Qu, J., Chen, D., Lv, Y., Li, H., & Zheng, J. (2020). Expression and prognostic significance of the P53‐related DNA damage repair proteins checkpoint kinase 1 (CHK1) and growth arrest and DNA‐damage‐inducible 45 alpha (GADD45A) in human oral squamous cell carcinoma. European journal of oral sciences, 128(2), 128-135.

Bourgeois, A., Bonnet, S., Breuils-Bonnet, S., Habbout, K., Paradis, R., Tremblay, E., ... & Boucherat, O. (2019). Inhibition of CHK 1 (checkpoint kinase 1) elicits therapeutic effects in pulmonary arterial hypertension. Arteriosclerosis, thrombosis, and vascular biology, 39(8), 1667-1681.

Halder, S., Torrecilla, I., Burkhalter, M. D., Popović, M., Fielden, J., Vaz, B., ... & Ramadan, K. (2019). SPRTN protease and checkpoint kinase 1 cross-activation loop safeguards DNA replication. Nature communications, 10(1), 1-18.

Hsu, W. H., Zhao, X., Zhu, J., Kim, I. K., Rao, G., McCutcheon, J., ... & Giaccone, G. (2019). Checkpoint kinase 1 inhibition enhances cisplatin cytotoxicity and overcomes cisplatin resistance in SCLC by promoting mitotic cell death. Journal of Thoracic Oncology, 14(6), 1032-1045.

Lowery, C. D., VanWye, A. B., Dowless, M., Blosser, W., Falcon, B. L., Stewart, J., ... & Stancato, L. F. (2017). The checkpoint kinase 1 inhibitor prexasertib induces regression of preclinical models of human neuroblastoma. Clinical Cancer Research, 23(15), 4354-4363.

Schuler, F., Weiss, J. G., Lindner, S. E., Lohmüller, M., Herzog, S., Spiegl, S. F., ... & Villunger, A. (2017). Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis. Nature communications, 8(1), 1-13.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Rabbit Anti-CHEK1 (Phospho-Ser345) Recombinant Antibody (CBWJC-2030)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Online Inquiry